These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27191703)

  • 1. Transcription Factor Drug Targets.
    Papavassiliou KA; Papavassiliou AG
    J Cell Biochem; 2016 Dec; 117(12):2693-2696. PubMed ID: 27191703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting transcription factors by small compounds--Current strategies and future implications.
    Hagenbuchner J; Ausserlechner MJ
    Biochem Pharmacol; 2016 May; 107():1-13. PubMed ID: 26686579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor based therapeutics: drugs of the future?
    Peterson MG; Baichwal VR
    Trends Biotechnol; 1993 Jan; 11(1):11-8. PubMed ID: 7763378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic modulation of transcription factor activity.
    Emery JG; Ohlstein EH; Jaye M
    Trends Pharmacol Sci; 2001 May; 22(5):233-40. PubMed ID: 11339974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors as therapeutic targets in CNS disorders.
    Kane MJ; Citron BA
    Recent Pat CNS Drug Discov; 2009 Nov; 4(3):190-9. PubMed ID: 19891598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-binding small molecules as inhibitors of transcription factors.
    Leung CH; Chan DS; Ma VP; Ma DL
    Med Res Rev; 2013 Jul; 33(4):823-46. PubMed ID: 22549740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription Factor Inhibition: Lessons Learned and Emerging Targets.
    Chen A; Koehler AN
    Trends Mol Med; 2020 May; 26(5):508-518. PubMed ID: 32359481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax-8: Molecular biology, pathophysiology, and potential pathogenesis.
    Zhou Q; Li H; Cheng Y; Ma X; Tang S; Tang C
    Biofactors; 2024; 50(3):408-421. PubMed ID: 37988248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer network activity associated with therapeutic response and synergism.
    Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
    Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs target hypoxia response in tumors.
    Garber K
    J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy.
    Sen E
    Drug Discov Today; 2011 Dec; 16(23-24):1044-51. PubMed ID: 21920453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of transcription factor deregulation in lymphoid cell transformation.
    O'Neil J; Look AT
    Oncogene; 2007 Oct; 26(47):6838-49. PubMed ID: 17934490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transcription factors with small organic molecules.
    Berg T
    Curr Opin Chem Biol; 2008 Aug; 12(4):464-71. PubMed ID: 18706517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC transporters as therapeutic targets: emerging opportunities.
    Lin L; Yee SW; Kim RB; Giacomini KM
    Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.
    Poser SW; Chenoweth JG; Colantuoni C; Masjkur J; Chrousos G; Bornstein SR; McKay RD; Androutsellis-Theotokis A
    Stem Cells Transl Med; 2015 Nov; 4(11):1251-7. PubMed ID: 26371344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes.
    Mansilla S; Priebe W; Portugal J
    Biochemistry; 2004 Jun; 43(23):7584-92. PubMed ID: 15182200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis.
    Tailleux A; Torpier G; Mezdour H; Fruchart JC; Staels B; Fiévet C
    Trends Pharmacol Sci; 2003 Oct; 24(10):530-4. PubMed ID: 14559405
    [No Abstract]   [Full Text] [Related]  

  • 18. Complex regulation of autophagy in cancer - integrated approaches to discover the networks that hold a double-edged sword.
    Kubisch J; Türei D; Földvári-Nagy L; Dunai ZA; Zsákai L; Varga M; Vellai T; Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):252-61. PubMed ID: 23810837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kavain Involvement in LPS-Induced Signaling Pathways.
    Tang X; Amar S
    J Cell Biochem; 2016 Oct; 117(10):2272-80. PubMed ID: 26917453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.